Literature DB >> 8914765

Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand.

R Ameratunga1, J McKee, J French, R Prestidge, W Fanslow, J Marbrook.   

Abstract

The X-linked hyper-immunoglobulin M syndrome (XHIM) is a primary immune deficiency disorder characterized by an inability to produce immunoglobulin isotypes other than immunoglobulin M (IgM) and IgD. Recently, a B-cell surface antigen (CD40) and its conjugate T-cell counterstructure (CD40 ligand) were shown to mediate immunoglobulin isotype switching in the presence of cytokines such as interleukin 4. Most patients with XHIM have been shown to have mutations of the extracellular domain of the CD40 ligand. Here we describe a novel point mutation of an intronic splice acceptor site which results in a complex splicing defect of the CD40 ligand in a patient with XHIM. In addition to two species of deleted transcripts, wild-type transcripts were also detected in this individual. The demonstration of wild-type CD40 ligand transcripts may be an explanation for previous observations suggesting that some XHIM patients are able to undergo immunoglobulin isotype switching in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914765      PMCID: PMC170437          DOI: 10.1128/cdli.3.6.722-726.1996

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Soluble forms of CD40 inhibit biologic responses of human B cells.

Authors:  W C Fanslow; D M Anderson; K H Grabstein; E A Clark; D Cosman; R J Armitage
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

2.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences.

Authors:  M Krawczak; J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

3.  Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases.

Authors:  F S ROSEN; S V KEVY; E MERLER; C A JANEWAY; D GITLIN
Journal:  Pediatrics       Date:  1961-08       Impact factor: 7.124

4.  Retinoic acid induced differentiated neuroblastoma cells show increased expression of the beta A4 amyloid gene of Alzheimer's disease and an altered splicing pattern.

Authors:  G König; C L Masters; K Beyreuther
Journal:  FEBS Lett       Date:  1990-09-03       Impact factor: 4.124

5.  Molecular cloning and characterization of grancalcin, a novel EF-hand calcium-binding protein abundant in neutrophils and monocytes.

Authors:  A Boyhan; C M Casimir; J K French; C G Teahan; A W Segal
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

6.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

Authors:  M B Shapiro; P Senapathy
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

7.  Correction of neutropenia associated with dysgammaglobulinemia.

Authors:  C H Rieger; J W Moohr; R M Rothberg
Journal:  Pediatrics       Date:  1974-10       Impact factor: 7.124

Review 8.  Immunodeficiency with hyper-IgM (HIM).

Authors:  L D Notarangelo; M Duse; A G Ugazio
Journal:  Immunodefic Rev       Date:  1992

9.  Molecular and biological characterization of a murine ligand for CD40.

Authors:  R J Armitage; W C Fanslow; L Strockbine; T A Sato; K N Clifford; B M Macduff; D M Anderson; S D Gimpel; T Davis-Smith; C R Maliszewski
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

10.  CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells.

Authors:  H H Jabara; S M Fu; R S Geha; D Vercelli
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  3 in total

1.  Increased risk of adverse events when changing intravenous immunoglobulin preparations.

Authors:  R Ameratunga; J Sinclair; J Kolbe
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

2.  Identification of germinal centres in the lymph node of a patient with hyperimmunoglobulin M syndrome associated with congenital rubella.

Authors:  Rohan Ameratunga; Chun-Jen J Chen; Wikke Koopmans; P Rod Dunbar; Maia Brewerton; Richard Lloydd; Claudia J Mansell; Chris van Vliet; See-Tarn Woon
Journal:  J Clin Immunol       Date:  2014-08-12       Impact factor: 8.317

3.  Cellular and molecular characterisation of the hyper immunoglobulin M syndrome associated with congenital rubella infection.

Authors:  Rohan Ameratunga; See-Tarn Woon; Wikke Koopmans; John French
Journal:  J Clin Immunol       Date:  2008-07-29       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.